These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37279796)

  • 1. Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodies.
    Okkels N; Horsager J; Labrador-Espinosa M; Kjeldsen PL; Damholdt MF; Mortensen J; Vestergård K; Knudsen K; Andersen KB; Fedorova TD; Skjærbæk C; Gottrup H; Hansen AK; Grothe MJ; Borghammer P
    Brain; 2023 Sep; 146(9):3690-3704. PubMed ID: 37279796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired cholinergic integrity of the colon and pancreas in dementia with Lewy bodies.
    Okkels N; Horsager J; Fedorova TD; Knudsen K; Skjærbæk C; Andersen KB; Labrador-Espinosa M; Vestergaard K; Mortensen JK; Klit H; Møller M; Danielsen EH; Johnsen EL; Bekan G; Hansen KV; Munk OL; Damholdt MF; Kjeldsen PL; Hansen AK; Gottrup H; Grothe MJ; Borghammer P
    Brain; 2024 Jan; 147(1):255-266. PubMed ID: 37975822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo.
    Klein JC; Eggers C; Kalbe E; Weisenbach S; Hohmann C; Vollmar S; Baudrexel S; Diederich NJ; Heiss WD; Hilker R
    Neurology; 2010 Mar; 74(11):885-92. PubMed ID: 20181924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes.
    Okkels N; Grothe MJ; Taylor JP; Hasselbalch SG; Fedorova TD; Knudsen K; van der Zee S; van Laar T; Bohnen NI; Borghammer P; Horsager J
    Brain; 2024 Jul; 147(7):2308-2324. PubMed ID: 38437860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
    Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D
    Brain; 2014 Sep; 137(Pt 9):2493-508. PubMed ID: 25062696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.
    Schumacher J; Kanel P; Dyrba M; Storch A; Bohnen NI; Teipel S; Grothe MJ
    Brain; 2023 Dec; 146(12):4964-4973. PubMed ID: 37403733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [
    Andersen KB; Hansen AK; Schacht AC; Horsager J; Gottrup H; Klit H; Danielsen EH; Poston KL; Pavese N; Brooks DJ; Borghammer P
    Mov Disord; 2023 May; 38(5):796-805. PubMed ID: 36905188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delusions and visual hallucinations in a patient with Parkinson's disease with dementia showing pronounced Lewy body pathology in the nucleus basalis of Meynert.
    Sakai K; Ikeda T; Ishida C; Komai K; Yamada M
    Neuropathology; 2019 Aug; 39(4):319-323. PubMed ID: 31243794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrophy of the Cholinergic Basal Forebrain can Detect Presynaptic Cholinergic Loss in Parkinson's Disease.
    Ray NJ; Kanel P; Bohnen NI
    Ann Neurol; 2023 May; 93(5):991-998. PubMed ID: 36597786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 123I-Iodobenzovesamicol SPECT Imaging of Cholinergic Systems in Dementia with Lewy Bodies.
    Mazère J; Lamare F; Allard M; Fernandez P; Mayo W
    J Nucl Med; 2017 Jan; 58(1):123-128. PubMed ID: 27469360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological substrates of mental dysfunction in Lewy body disease: an update.
    Jellinger KA
    J Neural Transm Suppl; 2000; 59():185-212. PubMed ID: 10961431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems.
    MacInnes N; Iravani MM; Perry E; Piggott M; Perry R; Jenner P; Ballard C
    J Neural Transm (Vienna); 2008 Jun; 115(6):869-78. PubMed ID: 18401540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
    Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
    Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia.
    Grothe MJ; Schuster C; Bauer F; Heinsen H; Prudlo J; Teipel SJ
    J Neurol; 2014 Oct; 261(10):1939-48. PubMed ID: 25059393
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Nedelska Z; Josephs KA; Graff-Radford J; Przybelski SA; Lesnick TG; Boeve BF; Drubach DA; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Whitwell JL; Kantarci K
    Mov Disord; 2019 Mar; 34(3):344-352. PubMed ID: 30615804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.
    Lee SH; Cho H; Choi JY; Lee JH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2018 Feb; 33(2):262-272. PubMed ID: 29168583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lewy body variant of Alzheimer's disease or cerebral type lewy body disease? Two autopsy cases of presenile onset with minimal involvement of the brainstem.
    Yokota O; Tsuchiya K; Uchihara T; Ujike H; Terada S; Takahashi M; Kimura Y; Ishizu H; Akiyama H; Kuroda S
    Neuropathology; 2007 Feb; 27(1):21-35. PubMed ID: 17319280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic connectomics targeting brain pathology in dementia with Lewy bodies.
    Caminiti SP; Tettamanti M; Sala A; Presotto L; Iannaccone S; Cappa SF; Magnani G; Perani D;
    J Cereb Blood Flow Metab; 2017 Apr; 37(4):1311-1325. PubMed ID: 27306756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
    Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
    J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the spectrum of neuronal pathology in multiple system atrophy.
    Cykowski MD; Coon EA; Powell SZ; Jenkins SM; Benarroch EE; Low PA; Schmeichel AM; Parisi JE
    Brain; 2015 Aug; 138(Pt 8):2293-309. PubMed ID: 25981961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.